Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SILO |
---|---|---|
09:32 ET | 312 | 0.92 |
09:33 ET | 999 | 0.92 |
09:37 ET | 100 | 0.9499 |
09:39 ET | 295 | 0.9305 |
09:44 ET | 200 | 0.95 |
09:46 ET | 300 | 0.93 |
09:48 ET | 4158 | 0.9111 |
09:50 ET | 100 | 0.911 |
09:53 ET | 100 | 0.911 |
09:57 ET | 29064 | 0.9 |
10:00 ET | 100 | 0.9 |
10:04 ET | 100 | 0.9 |
10:08 ET | 100 | 0.9 |
10:09 ET | 100 | 0.9 |
10:13 ET | 100 | 0.9 |
10:15 ET | 150 | 0.925 |
10:18 ET | 100 | 0.9 |
10:22 ET | 100 | 0.9 |
10:26 ET | 5100 | 0.9499 |
10:29 ET | 100 | 0.925 |
10:31 ET | 100 | 0.925 |
10:36 ET | 200 | 0.91 |
10:40 ET | 100 | 0.91 |
10:44 ET | 100 | 0.91 |
10:47 ET | 1013 | 0.94 |
10:49 ET | 300 | 0.95 |
10:51 ET | 100 | 0.91 |
10:58 ET | 300 | 0.9499 |
11:00 ET | 1063 | 0.95 |
11:02 ET | 100 | 0.91 |
11:05 ET | 100 | 0.91 |
11:07 ET | 9194 | 0.91 |
11:09 ET | 3100 | 0.9 |
11:14 ET | 41760 | 0.91 |
11:27 ET | 100 | 0.91 |
11:32 ET | 200 | 0.92 |
11:34 ET | 800 | 0.92 |
11:38 ET | 100 | 0.92 |
11:43 ET | 100 | 0.92 |
11:48 ET | 100 | 0.92 |
11:54 ET | 100 | 0.92 |
11:57 ET | 100 | 0.92 |
12:03 ET | 100 | 0.92 |
12:10 ET | 100 | 0.92 |
12:14 ET | 100 | 0.92 |
12:15 ET | 500 | 0.9201 |
12:19 ET | 100 | 0.9201 |
12:24 ET | 100 | 0.9202 |
12:26 ET | 100 | 0.9201 |
12:28 ET | 700 | 0.945 |
12:30 ET | 100 | 0.9201 |
12:35 ET | 100 | 0.9201 |
12:42 ET | 100 | 0.9201 |
12:48 ET | 100 | 0.9201 |
12:50 ET | 132 | 0.93255 |
12:51 ET | 100 | 0.9201 |
12:53 ET | 500 | 0.933 |
12:57 ET | 100 | 0.9201 |
01:04 ET | 200 | 0.945 |
01:09 ET | 100 | 0.9201 |
01:13 ET | 21446 | 0.9202 |
01:15 ET | 951 | 0.9 |
01:24 ET | 671 | 0.9266 |
01:27 ET | 300 | 0.9088 |
01:29 ET | 1000 | 0.9001 |
01:31 ET | 100 | 0.9001 |
01:36 ET | 1000 | 0.936 |
01:38 ET | 100 | 0.9001 |
01:40 ET | 200 | 0.9359 |
01:45 ET | 100 | 0.9001 |
01:49 ET | 100 | 0.9001 |
01:54 ET | 172 | 0.918 |
01:56 ET | 500 | 0.90036 |
02:02 ET | 3600 | 0.9001 |
02:05 ET | 100 | 0.9 |
02:07 ET | 150 | 0.9359 |
02:09 ET | 500 | 0.9001 |
02:12 ET | 100 | 0.9 |
02:18 ET | 200 | 0.91 |
02:20 ET | 200 | 0.9359 |
02:23 ET | 100 | 0.92 |
02:27 ET | 100 | 0.92 |
02:34 ET | 216 | 0.92 |
02:38 ET | 100 | 0.92 |
02:48 ET | 100 | 0.91 |
02:50 ET | 500 | 0.91 |
02:54 ET | 937 | 0.935239 |
02:57 ET | 100 | 0.91 |
02:59 ET | 310 | 0.91 |
03:03 ET | 100 | 0.91 |
03:06 ET | 253 | 0.936 |
03:08 ET | 100 | 0.91 |
03:12 ET | 100 | 0.9107 |
03:17 ET | 100 | 0.91 |
03:19 ET | 400 | 0.93 |
03:21 ET | 100 | 0.92 |
03:26 ET | 200 | 0.92 |
03:28 ET | 100 | 0.9206 |
03:32 ET | 100 | 0.92 |
03:35 ET | 400 | 0.9365 |
03:50 ET | 100 | 0.92 |
03:51 ET | 100 | 0.92 |
03:53 ET | 200 | 0.92 |
03:55 ET | 2962 | 0.9201 |
03:57 ET | 400 | 0.92 |
04:00 ET | 12438 | 0.924 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Silo Pharma Inc | 4.1M | -0.8x | --- |
Creative Medical Technology Holdings Inc | 4.3M | -0.6x | --- |
Galmed Pharmaceuticals Ltd | 4.2M | -0.1x | --- |
Quoin Pharmaceuticals Ltd | 4.0M | -0.1x | --- |
Transcode Therapeutics Inc | 4.0M | 0.0x | --- |
Oragenics Inc | 4.5M | -0.1x | --- |
Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It is engaged in acquiring and/or developing intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the potential benefits they may have in certain cases involving depression, mental health issues and neurological disorders. The Company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. Its SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Its two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1M |
---|---|
Revenue (TTM) | $72.1K |
Shares Outstanding | 4.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.45 |
EPS | $-1.16 |
Book Value | $2.13 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 57.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,624.03% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.